158 related articles for article (PubMed ID: 15014005)
1. Randomized, double-blind, placebo-controlled phase IIb trial of the cyclooxygenase inhibitor ketorolac as an oral rinse in oropharyngeal leukoplakia.
Mulshine JL; Atkinson JC; Greer RO; Papadimitrakopoulou VA; Van Waes C; Rudy S; Martin JW; Steinberg SM; Liewehr DJ; Avis I; Linnoila RI; Hewitt S; Lippman SM; Frye R; Cavanaugh PF
Clin Cancer Res; 2004 Mar; 10(5):1565-73. PubMed ID: 15014005
[TBL] [Abstract][Full Text] [Related]
2. Intranasal ketorolac for pain secondary to third molar impaction surgery: a randomized, double-blind, placebo-controlled trial.
Grant GM; Mehlisch DR
J Oral Maxillofac Surg; 2010 May; 68(5):1025-31. PubMed ID: 20207062
[TBL] [Abstract][Full Text] [Related]
3. NSAIDs for the chemoprevention of oral cancer: promise or pessimism?: Commentary re J. L. Mulshine et al., randomized, double-blind, placebo-controlled, phase IIB trial of the cyclooxygenase inhibitor ketorolac as an oral rinse in oropharyngeal leukoplakia. Clin. Cancer Res., 10: 1565-1573, 2004.
Goodin S; Shiff SJ
Clin Cancer Res; 2004 Mar; 10(5):1561-4. PubMed ID: 15014004
[No Abstract] [Full Text] [Related]
4. Cyclooxygenase inhibitor ketorolac or mast cell stabilizers: immunologic challenges in cancer therapy.
Khatami M
Clin Cancer Res; 2005 Feb; 11(3):1349-51; author reply 1351. PubMed ID: 15709209
[No Abstract] [Full Text] [Related]
5. Upper gastrointestinal safety evaluation of parecoxib sodium, a new parenteral cyclooxygenase-2-specific inhibitor, compared with ketorolac, naproxen, and placebo.
Harris SI; Kuss M; Hubbard RC; Goldstein JL
Clin Ther; 2001 Sep; 23(9):1422-8. PubMed ID: 11589257
[TBL] [Abstract][Full Text] [Related]
6. A Randomized Double-Blind Placebo-Controlled Phase IIB Trial of Curcumin in Oral Leukoplakia.
Kuriakose MA; Ramdas K; Dey B; Iyer S; Rajan G; Elango KK; Suresh A; Ravindran D; Kumar RR; R P; Ramachandran S; Kumar NA; Thomas G; Somanathan T; Ravindran HK; Ranganathan K; Katakam SB; Parashuram S; Jayaprakash V; Pillai MR
Cancer Prev Res (Phila); 2016 Aug; 9(8):683-91. PubMed ID: 27267893
[TBL] [Abstract][Full Text] [Related]
7. A double-blind, randomized comparison of intramuscularly and intravenously administered parecoxib sodium versus ketorolac and placebo in a post-oral surgery pain model.
Daniels SE; Grossman EH; Kuss ME; Talwalker S; Hubbard RC
Clin Ther; 2001 Jul; 23(7):1018-31. PubMed ID: 11519767
[TBL] [Abstract][Full Text] [Related]
8. Effects of ketorolac tromethamine mouthrinse (0.1%) on crevicular fluid prostaglandin E2 concentrations in untreated chronic periodontitis.
Preshaw PM; Lauffart B; Brown P; Zak E; Heasman PA
J Periodontol; 1998 Jul; 69(7):777-83. PubMed ID: 9706855
[TBL] [Abstract][Full Text] [Related]
9. A comparison of topical ketorolac, systemic flurbiprofen, and placebo for the inhibition of bone loss in adult periodontitis.
Jeffcoat MK; Reddy MS; Haigh S; Buchanan W; Doyle MJ; Meredith MP; Nelson SL; Goodale MB; Wehmeyer KR
J Periodontol; 1995 May; 66(5):329-38. PubMed ID: 7623251
[TBL] [Abstract][Full Text] [Related]
10. Parecoxib sodium demonstrates gastrointestinal safety comparable to placebo in healthy subjects.
Harris SI; Stoltz RR; LeComte D; Hubbard RC
J Clin Gastroenterol; 2004 Aug; 38(7):575-80. PubMed ID: 15232360
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of ketorolac concentrations in plasma and gingival crevicular fluid following topical treatment with oral rinses and dentifrices.
Kelm GR; Buchanan W; Meredith MP; Offenbacher S; Mankodi SM; Dobrozsi DJ; Bapat NV; Collins JG; Wehmeyer KR; Eichhold TH; Doyle MJ
J Pharm Sci; 1996 Aug; 85(8):842-7. PubMed ID: 8863274
[TBL] [Abstract][Full Text] [Related]
12. Intranasal ketorolac for postoperative pain: a phase 3, double-blind, randomized study.
Brown C; Moodie J; Bisley E; Bynum L
Pain Med; 2009 Sep; 10(6):1106-14. PubMed ID: 19594851
[TBL] [Abstract][Full Text] [Related]
13. A double-blind prospective comparison of rofecoxib vs ketorolac in reducing postoperative pain after arthroscopic knee surgery.
Kim JT; Sherman O; Cuff G; Leibovits A; Wajda M; Bekker AY
J Clin Anesth; 2005 Sep; 17(6):439-43. PubMed ID: 16171664
[TBL] [Abstract][Full Text] [Related]
14. Single doses of parecoxib sodium intravenously are as effective as ketorolac in reducing pain after oral surgery.
Mehlisch DR; Desjardins PJ; Daniels S; Hubbard RC
J Oral Maxillofac Surg; 2003 Sep; 61(9):1030-7. PubMed ID: 12966478
[TBL] [Abstract][Full Text] [Related]
15. Ketorolac versus acetaminophen-codeine in the emergency department treatment of acute low back pain.
Innes GD; Croskerry P; Worthington J; Beveridge R; Jones D
J Emerg Med; 1998; 16(4):549-56. PubMed ID: 9696169
[TBL] [Abstract][Full Text] [Related]
16. Sublingual ketorolac versus sublingual tramadol for moderate to severe post-traumatic bone pain in children: a double-blind, randomised, controlled trial.
Neri E; Maestro A; Minen F; Montico M; Ronfani L; Zanon D; Favret A; Messi G; Barbi E
Arch Dis Child; 2013 Sep; 98(9):721-4. PubMed ID: 23702435
[TBL] [Abstract][Full Text] [Related]
17. Coordinate production of PGE2 and IL-1 beta in the gingival crevicular fluid of adults with periodontitis: its relationship to alveolar bone loss and disruption by twice daily treatment with ketorolac tromethamine oral rinse.
Cavanaugh PF; Meredith MP; Buchanan W; Doyle MJ; Reddy MS; Jeffcoat MK
J Periodontal Res; 1998 Feb; 33(2):75-82. PubMed ID: 9553866
[TBL] [Abstract][Full Text] [Related]
18. Comparing parecoxib and ketorolac as preemptive analgesia in patients undergoing posterior lumbar spinal fusion: a prospective randomized double-blinded placebo-controlled trial.
Siribumrungwong K; Cheewakidakarn J; Tangtrakulwanich B; Nimmaanrat S
BMC Musculoskelet Disord; 2015 Mar; 16():59. PubMed ID: 25886746
[TBL] [Abstract][Full Text] [Related]
19. Effects of the 2-amino-3-hydroxy-5-methyl-4-isoxazole-proprionic acid/kainate antagonist LY293558 on spontaneous and evoked postoperative pain.
Gilron I; Max MB; Lee G; Booher SL; Sang CN; Chappell AS; Dionne RA
Clin Pharmacol Ther; 2000 Sep; 68(3):320-7. PubMed ID: 11014414
[TBL] [Abstract][Full Text] [Related]
20. IM ketorolac vs diclofenac potassium powder for oral solution for the acute treatment of severe migraine: a randomized controlled trial.
Engel ER; Cheng J
Neurol Sci; 2020 Mar; 41(3):537-542. PubMed ID: 31833000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
